Genetic constructs for localised population suppression of pest species

Reference number 11457

Sectors: Biotechnology

Industries: Agriculture, Biotechnology

Proposed use

The technology described is expected to give efficient and localised suppression of wild populations. Potential applications include control of sexually reproducing pest populations which cannot be satisfactorily controlled with current interventions. Examples include populations of disease vectors, agricultural pests, or undesired invasive species. The types of pest species targetable may include, but is not limited to, insects, other invertebrates (e.g. clams), mammals, other vertebrates (e.g. fish) and weeds..

Technology overview

The invention consists of a genetic construct inserted into members of a species (or of organisms that have been genetically engineered to carry a genetic construct inserted into the genome). Individuals with the construct are released into a population. The effect of releasing individuals with the construct into the population will be to suppress the population in an efficient and localised manner over a period of time.

Said construct comprises genes which encode a genome editor which edits a natural existing gene in the genome to create dominant lethal or sterile mutations. The gene(s) encoding the editor are flanked by control sequences that ensure it is active in the male and female germline, such that a large fraction of the progeny inherit the dominant lethal or sterile edit. Optionally, it may be active in other tissues, but individuals carrying the construct should have normal or close to normal fitness.

The choice of insertion site and target site, and the design of the construct is such that individuals inheriting the construct are little affected by the dominant edits it creates, and have normal or close to normal fitness, whereas progeny not inheriting the construct (that inherit the alternate allele) die or are sterile. In principle, this can be achieved in multiple ways including inserting the construct within or near to a haplosufficient gene required for fertility or survival in both sexes such that it disrupts function or is linked to an existing recessive mutation (figure 1) and engineering it to create dominant mutations in either the same (figure 1a) or different gene (figure 1b and c).

Figure 1

Illustration of proposed molecular configurations for various embodiments of the construct according tot he invention, giving localised population suppression.

Figure 1 illustrates proposed molecular configurations for various embodiments of the construct according to the invention, giving localised population suppression

Benefits

  • The proposed constructs consist of genes which encode a genome editor which edits a natural existing gene in the genome to create dominant lethal or sterile mutations.
  • Said construct is inserted into the genome in such a way that it disrupts a haplotype-sufficient gene that is needed for survival or reproduction of males and females.
  • Optionally, the construct may be inserted into and disrupt a gene whose loss can be masked in the laboratory and in the released individuals, so that a pure-breeding strain can be produced.
  • The fitness costs imposed by the construct design could potentially be suppressed by use of a Cas9 inhibitor, to allow for the transgenic organism to be maintained as a pure breeding line, reducing rearing costs and time.

Intellectual Property information

PCT Patent Application No. PCT/GB2023/053269

 

Inventors

Professor Austin Burt

Professor of Evolutionary Genetics
Department of Life Sciences, Faculty of Natural Sciences

Visit personal site
Dr Katie Willis

Research Associate
Department of Life Sciences, Faculty of Natural Sciences

Visit personal site

Contact

Edmond Yau

Industry Partnerships and Commercialisation Executive – Faculty of Natural Sciences

Edmond joined Imperial in February 2022 as an Industry Partnerships and Commercialisation Executive. He primarily takes care of IP and licensing cases from the Faculty of Natural Sciences. Prior to joining Imperial, Edmond worked in Royal College of Art as Intellectual Property Manager who assists with queries regarding intellectual property especially patents and copyrights. Edmond has rich experience in transferring technology from tertiary institution to private sector before he moved to the UK. Edmond worked in the Hong Kong University of Science and Technology and the Chinese University of Hong Kong for more than a decade handling around several hundreds of inventions and thousands of patent applications/patents from Faculties of Engineering, Science and Medicine. He was also responsible for advising on IP strategy, patent prosecution, and the resolution of IP ownership. In addition to this, Edmond was in charge of the invention disclosure process, patent prosecution as well as licensing negotiations. He handled various types of agreements, including confidentiality, licensing, joint-ownership and royalty sharing agreements. Edmond is a patent agent by training (qualified in the People Republic of China in 2016), with his first degree in Chemical Engineering and a Master degree in Laws specialised in IP Laws from the […]

Contact Edmond

[email protected]

Related technologies

A real-time fluorescence probe for Heme Oxygenase activity

A real-time fluorescence probe for Heme Oxygenase activity

Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders. Find out more

An Inducible, multiplexed CRISPR system

An Inducible, multiplexed CRISPR system

A CRISPR-based platform for inducibly up- and down-regulating up to 24 genes in the yeast, Saccharomyces cerevisiae. Find out more

anti-TCRVbeta Chimeric Antigen Receptors (CARs)

anti-TCRVbeta Chimeric Antigen Receptors (CARs)

anti-TCRVbeta Chimeric Antigen Receptors which can target pathological T cells in a highly selective manner, leaving >90% of the patient's T cells and T cell-dependent immunity intact. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...